MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected...

APPG calls for long term conditions to be part of new pharmacy contract

APPG calls for long term conditions to be part of new pharmacy contract

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

RPS seeks views on draft guidance around polypharmacy

RPS seeks views on draft guidance around polypharmacy

July 13 2018 The Royal Pharmaceutical Society is seeking comments to hone draft guidance on...

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20...

  • MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    Thursday, 19 July 2018 10:29
  • APPG calls for long term conditions to be part of new pharmacy contract

    APPG calls for long term conditions to be part of new pharmacy contract

    Monday, 16 July 2018 15:44
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:51
  • RPS seeks views on draft guidance around polypharmacy

    RPS seeks views on draft guidance around polypharmacy

    Friday, 13 July 2018 12:47
  • NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    Wednesday, 11 July 2018 13:02

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a green cross imageJune 6 2018

Pharmacists should be better integrated into services providing care for people with mental health conditions, the Royal Pharmaceutical Society in England has said. It would mean patients would receive better care and involving pharmacist would help tackle the health inequalities people with mental health conditions currently experience.

The RPS is launching a new report, ‘No health without mental health: How can pharmacy support people with mental health problems?’, which provides recommendations about how pharmacists can be better utilised as part of the multidisciplinary team in mental health.

The RPS is calling for:

  • Pharmacists to be commissioned to provide physical health monitoring and management of people with mental health conditions, which requires full access to the patient's record
  • Identify how pharmacists in community settings can be enabled to better support people with mental health problems with their medicines, such as through the inclusion of antidepressants in a service like the New Medicine Service
  • Every mental health team to have access to a specialist mental health pharmacist, to provide support to the multidisciplinary team across a variety of settings

“People with mental health problems often have more difficulty accessing healthcare than others and the life expectancy of those with a serious mental illness is 15-20 years less than average,” said the Society.

“Their physical health often suffers due to difficulties in managing their long-term condition in a regular, coherent way and their additional health risks include diabetes, obesity, high blood pressure, lack of exercise and smoking.”

RPS England Board Chair Sandra Gidley added: “Mental and physical health are interwoven yet the treatment gap is enormous. The significantly poorer health of people with mental health conditions is shaming and must be tackled. 

“It’s crucial that the Government and the NHS make the most of the pharmacy workforce to better support patients and commission services which integrate pharmacists into care pathways that can better support patients.”

Professor David Baldwin, Chair of the Psychopharmacology Committee of the Royal College of Psychiatrists said that pharmacists have a “pivotal role” in mental health care, both in the safe supply of medicines and information. 

“Pharmacists can also detect symptoms which suggest someone might be becoming mentally or physically unwell, and can involve other health professionals when concerned about patients.,” he said.

“Psychiatrists recognise the important role of pharmacists in helping patients make the best use of their medicines, including their efforts to support patients when pharmacological treatment is not suitable or no longer needed. We therefore welcome this new initiative from the Royal Pharmaceutical Society.”

Links:
RPS announcement      
Royal Pharmaceutical Society. ‘No health without mental health: How can pharmacy support people with mental health problems?’. June 2018.      

Practice News

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected adverse drug reactions associated with medicines taken during pregnancy.
July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20 hypertensive patients without the need to refer a patient back to the GP. Analysis of 131,419 patient...